Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-002430
Filing Date
2024-11-01
Accepted
2024-11-01 16:27:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422sepn_11012024.htm SC 13G 275618
2 JOINT FILING AGREEMENT ex991tosc13g07422sepn_110124.htm EX-99.1 8324
  Complete submission text file 0000921895-24-002430.txt   285612
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Subject) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94678 | Film No.: 241419424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)